Investors in BB Biotech can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Analysts expect a dividend of 3,18 CHF per share. BB Biotech 's dividend yield thus equals 4,67 percent. The average dividend yield of the biotech companies equals a low 0,5 percent.
Tomorrow the Swiss BB Biotech will publish its past quarter's figures. Over the current book year the total revenue will be 0 million CHF (consensus estimates). This is hugely lower than 2017's revenue of 730,05 million CHF.
The analysts expect for 2018 a net profit of 362 million CHF. For this year most of the analysts expect a profit per share of 11,82 CHF. With this the price/earnings-ratio is 5,77.
BB Biotech 's market capitalization is based on the number of outstanding shares around 3,77 billion CHF. At 10.49 the stock trades 0,22 percent higher at 68,15 CHF.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.